Back to Search
Start Over
A Phase I Vaccine Safety and Chemotherapy Dose-Finding Trial of an Allogeneic GM-CSF–Secreting Breast Cancer Vaccine Given in a Specifically Timed Sequence with Immunomodulatory Doses of Cyclophosphamide and Doxorubicin. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland
- Source :
- Human Gene Therapy. 15:313-337
- Publication Year :
- 2004
- Publisher :
- Mary Ann Liebert Inc, 2004.
- Subjects :
- Oncology
Chemotherapy
medicine.medical_specialty
Cyclophosphamide
medicine.drug_class
business.industry
medicine.medical_treatment
Genetic enhancement
Allogeneic GM-CSF-Secreting Breast Cancer Vaccine
Antibiotics
medicine.disease
Dose finding
Breast cancer
Internal medicine
Immunology
Genetics
medicine
Molecular Medicine
Doxorubicin
business
Molecular Biology
medicine.drug
Subjects
Details
- ISSN :
- 15577422 and 10430342
- Volume :
- 15
- Database :
- OpenAIRE
- Journal :
- Human Gene Therapy
- Accession number :
- edsair.doi...........41c17ad2c43e5bc085c85aac5c838bb0